Evidence map›Paper›PMID 22104105›Full record

ArticleInfection and immunity2012

Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model.

Patricia I Diaz, Zhihong Xie, Takanori Sobue, Angela Thompson, Basak Biyikoglu, Austin Ricker, Laertis Ikonomou, Anna Dongari-Bagtzoglou

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 147 papers.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 227 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Synergistic interactions betweenProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Reproducible 3D bioprinting ofMicrobiology spectrum · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Streptococcus dentisani inhibits the growth of Candida albicans and Candida glabrata: in vitro assay.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  11. The Oral Microbiome: A Key Determinant of Oral Health.Advances in experimental medicine and biology · 2025
    Review
  12. Multifaceted roles ofFrontiers in cellular and infection microbiology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Patricia I DiazDivision of Periodontology, Department of Oral Health and Diagnostic Sciences, The University of Connecticut Health Center, Farmington, Connecticut, USA. pdiaz@uchc.edu
Zhihong Xie
Takanori Sobue
Angela Thompson
Basak Biyikoglu
Austin Ricker
Laertis Ikonomou
Anna Dongari-Bagtzoglou
UConn Health · USBoston University · US

Funding

Oral Epithelial Cells, Candida and PMN ActivationR01DE013986 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Anna I Dongari-Bagtzoglou · 2000 to 2026
$9.2M
Novel flow cell model to study oral mucosa-polymicrobial biofilm interactionsR21DE020166 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DIAZ, PATRICIA · 2010 to 2011
$420k
NIDCR NIH HHS R01 DE013986NIDCR NIH HHS R01DE013986NIDCR NIH HHS R21 DE020166NIDCR NIH HHS R21DE020166
6 · The paper itself

Abstract

Candida albicans is a commensal colonizer of the gastrointestinal tract of humans, where it coexists with highly diverse bacterial communities. It is not clear whether this interaction limits or promotes the potential of C. albicans to become an opportunistic pathogen. Here we investigate the interaction between C. albicans and three species of streptococci from the viridans group, which are ubiquitous and abundant oral commensal bacteria. The ability of C. albicans to form biofilms with Streptococcus oralis, Streptococcus sanguinis, or Streptococcus gordonii was investigated using flow cell devices that allow abiotic biofilm formation under salivary flow. In addition, we designed a novel flow cell system that allows mucosal biofilm formation under conditions that mimic the environment in the oral and esophageal mucosae. It was observed that C. albicans and streptococci formed a synergistic partnership where C. albicans promoted the ability of streptococci to form biofilms on abiotic surfaces or on the surface of an oral mucosa analogue. The increased ability of streptococci to form biofilms in the presence of C. albicans could not be explained by a growth-stimulatory effect since the streptococci were unaffected in their growth in planktonic coculture with C. albicans. Conversely, the presence of streptococci increased the ability of C. albicans to invade organotypic models of the oral and esophageal mucosae under conditions of salivary flow. Moreover, characterization of mucosal invasion by the biofilm microorganisms suggested that the esophageal mucosa is more permissive to invasion than the oral mucosa. In summary, C. albicans and commensal oral streptococci display a synergistic interaction with implications for the pathogenic potential of C. albicans in the upper gastrointestinal tract.

Indexed as

Bacteriological TechniquesBiofilmsCandida albicansCoculture TechniquesEsophagusHumansModels, BiologicalMouth MucosaSalivaSpecies SpecificityViridans Streptococci

Identifiers

PMID22104105
PMCPMC3264323
OpenAlexW2169530108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.